Table I.
Characteristics | All patients, n (%) | Low-expression group, n (%) | High-expression group, n (%) | P-value |
---|---|---|---|---|
Total | 189 (100) | 76 (40) | 113 (60) | |
Age, years | ||||
Median | 65 | 64 | 66 | 0.271a |
Range | 33–88 | 33–88 | 43–86 | |
Gender | ||||
Female | 77 (41) | 29 (38) | 48 (42) | 0.659b |
Male | 112 (59) | 47 (62) | 65 (58) | |
Tumor location | ||||
Colon | 119 (63) | 56 (74) | 63 (56) | 0.019b |
Rectum | 70 (37) | 20 (26) | 50 (44) | |
Differentiation | ||||
Well | 39 (21) | 15 (20) | 24 (21) | 0.733b |
Moderate | 136 (72) | 54 (71) | 82 (73) | |
Poor | 14 (7) | 7 (9) | 7 (6) | |
Stage grouping | ||||
Duke's A | 87 (46) | 35 (46) | 52 (46) | 1.000b |
Duke's B, C | 102 (54) | 41 (54) | 61 (54) | |
Tumor depth | ||||
pT1,2 | 35 (19) | 9 (12) | 26 (23) | 0.081b |
pT3,4 | 154 (81) | 67 (88) | 87 (77) | |
Lymph node metastasis | ||||
N0 | 94 (50) | 38 (50) | 56 (50) | 1.000b |
N1,2 | 95 (50) | 38 (50) | 57 (50) | |
Distant metastasis | ||||
M0 | 156 (83) | 60 (79) | 96 (85) | 0.383b |
M1 | 33 (17) | 16 (21) | 17 (15) | |
Lymphatic invasion | ||||
Ly0,1 | 133 (70) | 50 (66) | 83 (73) | 0.333b |
Ly2,3 | 56 (30) | 26 (34) | 30 (27) | |
Venous invasion | ||||
V0,1 | 126 (67) | 49 (64) | 77 (68) | 0.714b |
V2,3 | 63 (33) | 27 (36) | 36 (32) | |
SN-38 effect, T/C | ||||
Median | 66 | 55 | 73 | <0.001a |
Range | 21–100 | 21–100 | 32–100 | |
Sensitive, T/C <60 | 77 (41) | 56 (74) | 21 (19) | <0.001b |
Resistant, T/C ≥60 | 112 (59) | 20 (26) | 92 (81) |
P-values were obtained from Student's t-tests.
P-values were obtained from χ2 tests. TNM, tumor-node-metastasis; T/C, ratio of the total colony volume of the treated group (T) to that of the control group (C).